National Immunization Program PNLE Questions
Introduction
The live inventory contains 42 original PNLE-style practice questions for National Immunization Program. The items cover vaccine schedules, eligibility, administration, counseling, cold-chain handling, and logistics, all within NP3, Community Health.
Study this topic as a chain of safe decisions: identify who should receive a vaccine, verify the dose history and current program guidance, screen for contraindications or precautions, prepare and administer correctly, protect product quality, and communicate the next action. The scope includes routine and catch-up immunization, high-risk client considerations, and reaching zero-dose children; it excludes non-vaccine disease prevention and outbreak investigation.
National Immunization Program is a Tangerine pedagogical lens mapped across relevant competencies in the official five-subject PNLE TOS, not a separate official test subject. The 2025 Enhanced TOS supplies broad competency weights, not a guaranteed microtopic count, so use this inventory to build decisions rather than predict an exam form.
Key concepts
- Schedule and catch-up reasoning
Recognize: Age, dose history, birth-dose status, and missed opportunities are separate clues in the stem.
Decide: Match the record to the current routine or catch-up schedule used by the immunization program, then identify the next indicated action.
Avoid: Inventing intervals, treating a missed dose as permanent ineligibility, or automatically restarting a series without program direction. - Eligibility is vaccine-specific
Recognize: Eligibility depends on the client, the specific vaccine, prior doses, and the indication being tested.
Decide: Review the client record and applicable program guidance before selecting the vaccine or deferring it.
Avoid: Applying one vaccine's eligibility rule to every product or assuming that an incomplete record proves that no dose was given. - Screen before administration
Recognize: The stem may provide allergy history, current illness, immune status, pregnancy status, or other screening information.
Decide: Separate true contraindications and precautions from conditions that require assessment or clarification, using the current program guidance for the product.
Avoid: Giving the dose before screening is complete or rejecting vaccination based on a vague symptom alone. - Mild illness versus a safety stop
Recognize: A mild afebrile illness and a documented serious allergic reaction represent different decision cues.
Decide: Assess the client's condition and follow product-specific guidance; mild afebrile illness alone is not an automatic reason to defer, while a serious allergy requires resolution before proceeding.
Avoid: Using the shortcut that every illness prevents vaccination or that every previous reaction has the same significance. - Product preparation and administration
Recognize: Product identity, expiry, route, site, equipment, reconstitution, and documentation all affect safe delivery.
Decide: Check the label and applicable program or manufacturer procedure before preparing and administering the dose, then record the service accurately.
Avoid: Relying on memory when instructions are available, mixing products incorrectly, or documenting an intended dose as though it had been given. - Cold chain and diluent integrity
Recognize: Temperature checks, storage records, expiry, and the specified diluent provide evidence that a vaccine remains suitable for use.
Decide: Use only the diluent designated for that product and follow the program process when storage integrity is uncertain.
Avoid: Substituting a convenient diluent, ignoring an unexplained temperature excursion, or releasing questionable stock without disposition guidance. - Counseling and immunization logistics
Recognize: Questions about expected responses, return visits, access barriers, zero-dose children, and high-risk clients affect completion of protection.
Decide: Give clear, program-consistent instructions, document the plan, and link the client or household to the next service opportunity.
Avoid: Giving vague reassurance, omitting follow-up instructions, or confusing immunization outreach with non-vaccine prevention or outbreak investigation.
What to expect on the PNLE
The live set contains 31 easy, 7 medium, and 4 hard items. Its Bloom distribution is 26 remembering, 11 applying, 2 understanding, 1 analyzing, and 2 evaluating. This supports strong retrieval of core facts with some work translating a client record, screening cue, storage problem, or logistics calculation into a safe action; it does not predict the difficulty or cognitive mix of a future form.
Question forms supported by the inventory include selecting an eligible group, identifying the next routine or catch-up step, screening before a dose, choosing the correct product preparation process, interpreting cold-chain checks, and selecting counseling or outreach actions. Some stems ask for a single best decision, while others require comparing a documented history with program guidance or estimating an immunization planning need.
- Read the client, vaccine, and dose-history cues before judging the options.
- For administration items, look for product identity, diluent, storage, and documentation details.
- For counseling and logistics items, select the action that supports safe completion and access.
- Exact topic distribution varies by exam form, so prepare across the full canonical scope rather than assigning a guaranteed number to one microtopic.
Study tips
- Start with a diagnostic set. Answer a short mixed group of National Immunization Program items before reviewing notes. Mark each response as schedule, eligibility, administration, counseling, cold chain, or logistics, and record whether the error came from recall, interpretation, or an unsafe action choice.
- Use focused retrieval. Build a blank comparison grid and fill it from memory before checking references. Comparison table to draw:Keep exact schedule details tied to the current program material rather than guessing unsupported numbers.
Client cue | Schedule or eligibility check | Administration or storage check | Counseling or next action
Missed dose | Allergy or illness clue | Diluent or temperature issue | Zero-dose or high-risk access issue - Review every rationale and error. For each missed item, write the decisive cue, the safest action, and why the chosen distractor failed. Pay special attention to stems that distinguish a mild afebrile illness from a serious allergic reaction or a valid product from questionable stock.
- Retry with spacing. Re-answer missed and uncertain items in a later study session without looking at the explanation first. Continue until you can state the decision rule and the safety check, not merely recognize the answer choice.
- Finish with mixed timed practice. Combine schedule, screening, preparation, cold-chain, counseling, and logistics items so you must switch decision types under time pressure. Review rationales after timing ends, then return difficult items to the next spaced-retry cycle.
Common mistakes to avoid
- Memorizing a schedule without reading the record. Learners may choose a routine dose while overlooking age, birth-dose status, or previous doses. The correcting cue is the client's documented history; use the current routine or catch-up framework and identify the next indicated action.
- Deferring every child with an illness. A mild afebrile illness alone is not an automatic deferral. Assess the condition and apply product-specific guidance instead of using the unsafe shortcut that any symptom blocks immunization.
- Missing a serious allergy clue. A documented anaphylactic reaction related to the vaccine or a component is a safety stop that requires resolution under current guidance. Do not treat it as an ordinary post-vaccination response or proceed simply because the client is due.
- Substituting a diluent or ignoring storage uncertainty. The correct cue is product integrity, not convenience. Use only the specified diluent, check storage records, and hold questionable stock for the required program disposition process.
- Choosing outreach actions outside the immunization task. A question about zero-dose children, high-risk clients, or pregnant clients needing tetanus-containing immunization calls for an immunization access or planning decision. Keep the response within vaccination logistics rather than shifting to general disease prevention or outbreak investigation.
Try a question
A real National Immunization Program question from our bank. Give it a shot.
A healthy newborn is ready for discharge after an uncomplicated birth. When should routine BCG vaccination be provided under the national immunization program?
The Bacillus Calmette-Guérin (BCG) vaccine is administered to protect infants and young children against severe forms of tuberculosis (TB), such as TB meningitis and miliary TB. The Philippines' National Immunization Program advocates for BCG to be given as early as possible, typically at birth or shortly thereafter, to maximize early protection in a country with intermediate to high tuberculosis prevalence.
Why the correct option is correct
Option A is correct because the Department of Health (DOH) of the Philippines recommends BCG vaccination at birth or as soon as possible after birth, ideally before hospital discharge. Newborn immune systems are able to respond to the live attenuated vaccine, and timely administration provides early protection during the period of greatest vulnerability to TB complications. Postponing vaccination reduces the window of protection and increases the risk for severe TB infections in early infancy, especially in high-risk settings.
Clinical pearl: In high-burden TB countries like the Philippines, early BCG administration (before six weeks of age) is essential for preventing potentially fatal TB in young children.
Why the other options are incorrect
| Option | Why it is wrong |
|---|---|
| B | BCG is not delayed until school entry; this would leave young children susceptible during their highest-risk years for severe TB. Early immunization at birth is specifically recommended to protect infants as soon as possible. |
| C | A history of tuberculosis exposure in the household is not required for BCG. The vaccine is given universally to all neonates as part of the routine schedule, irrespective of known exposure, due to the endemic nature of TB. |
| D | The BCG vaccine is given without prior tuberculin skin testing in newborns. Tuberculin testing is not routinely performed prior to BCG in infancy, as it is used primarily for older children or adults to diagnose latent infection. |
Maglaya, A. S. (Ed.). (2009). Nursing practice in the community (5th ed.). Argonauta Corporation.
Hinkle, Janice L., Cheever, Kerry H., & Overbaugh, Kristen J. (2022). Brunner & Suddarth's Textbook of Medical-Surgical Nursing (15th ed.). Wolters Kluwer. https://shop.lww.com/Brunner---Suddarth-s-Textbook-of-Medical-Surgical-Nursing/p/9781975161033
More National Immunization Program questions
42 questions available. Sign up to practice all of them.
A nurse is preparing a freeze-dried measles-containing vaccine during an outreach session. Which diluent should be used for reconstitution?
At closing time, a rural health nurse notices that only the morning vaccine-refrigerator temperature was recorded. The unit remained open all day and no continuous digital record is available. What should the nurse identify as the missed routine action?
Four infants are due for BCG vaccination. Which finding requires withholding BCG and obtaining clinical guidance before vaccination?
References and further reading
- PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward. - Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.
How this page is built
The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on August 12, 2026.
The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.